ASCO Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Update – Key Changes

from Clinical Guideline InSights · host Guideline Central

A rapid update of the 2026 Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer guideline, highlighting key updates across recommendations on predictive biomarker testing, first-line therapy, and second- or third-line therapyImmunotherapy and Targeted Therapy for Advanced Gastroesophageal CancerAmerican Society of Clinical OncologyFebruary 26th, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/2352151/Full-Text: https://ascopubs.org/doi/full/10.1200/JCO-25-02958

Episode metadata supplied by the publisher feed · Published Mar 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

ASCO Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Update – Key Changes

0:00 5:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 5 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on March 11, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!